Fortune Magazine, a globally renowned publication, has officially unveiled its prestigious “China’s Most Influential Women in Business” list for the year 2023. Among the distinguished honorees, Teresa, the CEO of HTDK, has been recognized as one of China’s most influential businesswomen of the future. This accolade celebrates her exceptional leadership within the medical device cross-border business solutions platform and her extensive contributions to the healthcare industry.

Teresa’s inclusion in this prestigious list highlights the remarkable ascent of female leaders as a formidable force in the business landscape. It also underscores HTDK’s unwavering commitment to fostering a culture of diversity and inclusivity, as well as the promotion of women’s leadership. The company actively contributes to the pursuit of gender equality, exemplifying its dedication to creating a more equitable world.

Fortune Magazine’s “China’s Most Influential Women in Business” list has been a yearly tradition since 2010. Over the past decade, it has showcased outstanding women from various sectors in China, recognizing their wisdom, courage, determination, and confidence in the corporate world. In 2020, Fortune introduced the “China’s Most Influential Businesswomen of the Future” category, designed to spotlight emerging women leaders shaping the future of business.

In a landscape characterized by increasing healthcare demands and aging demographics, the demand for high-value medical devices is on the rise, necessitating the entry of overseas brands into the Chinese market. As the CEO of HTDK, Teresa has leveraged her extensive expertise to guide her team in executing an agile transformation. They continually innovate their business models, providing comprehensive, customized, and digital solutions to cater to the diverse needs of multinational medical device manufacturers at various stages of development. Moreover, Teresa has astutely recognized opportunities in the Chinese market for global high-precision and innovative medical devices, actively promoting their integration.

Under Teresa’s leadership, HTDK’s executive team has established an open innovation ecosystem, fostering collaboration with suppliers, partners, and manufacturers across various domains, such as in vitro diagnostics, ophthalmology, orthopedics, cardiology, neurology, and vascular surgery. They have accelerated the development of digital innovations, business models, and professional standards, thereby propelling the industry towards long-term growth and mutually beneficial outcomes.

Teresa’s exceptional market insight and business acumen have significantly elevated HTDK’s brand positioning and influence in the Chinese market. Her strategic leadership has driven the company to achieve sustained growth, establishing HTDK as a leader in cross-border business solution platforms. This success extends beyond mere business metrics, as it enhances both the business and social value delivered to users.

HTDK and its visionary CEO, Teresa, are committed to shaping the future of the healthcare industry and the business world at large. This recognition by Fortune Magazine reflects their dedication to innovation, inclusivity, and excellence.